Debunking EBM / Public Health

BGR-34 for Diabetes: Where is the evidence?

An herbal drug, developed jointly by the National Botanical Research Institute (NBRI) and the Central Institute of Medicinal and Aromatic Plants (CIMAP), branded as BGR-34, has been commercialized by Delhi-based Aimil Pharmaceuticals and marketed as a potentially side-effect free treatment for diabetes. However, a search for publications outlining trials conducted to support the claimed “67% … Continue reading

Rate this:

Infectious Diseases / Public Health

Turning to the “Infected Jelly” to Treat Ebola

The NEJM has come out with a very interesting paper: Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. The explosive outbreak of Ebola Virus Disease in West Africa last year had hijacked the headlines and media space in a big way. Multiple solutions were touted, including the vaccine trial STRIVE. Few articles, however, looked … Continue reading

Rate this:

Infectious Diseases / Public Health

If Carbapenems Go, Can Colistin be Far Behind?

I wrote about the disaster-in-the-making discovery of transmissible resistance to colistin, a last resort antibiotic, when the Lancet Infectious Diseases published a paper based on data coming out from surveillance in China. At that point of time, the isolation of the transmissible gene providing resistance (mcr1 gene) gained a lot of attention. Maryn McKenna’s blog post went … Continue reading

Rate this:

Infectious Diseases / Public Health / Research Round-Up

Weekly Research Round-up #1: January 1-7

This is a recap of all the research articles I found interesting, especially those related to infectious diseases, emerging and reemerging infections, antimicrobial resistance and One Health or EcoHealth approach. This is a regular new series I intend to write about on a regular basis. Should AED Devices Be Routinely Included in Wilderness Medical Kits? … Continue reading

Rate this:

Towards Universal Health Coverage: The Lancet Commission and Some Personal Thoughts
Medcetera / Public Health

Towards Universal Health Coverage: The Lancet Commission and Some Personal Thoughts

The Lancet Commission on Investing in Health (CIH) has come up with an ambitious framework (1) and an editorial comment accompanying it (2) in the recent issue of the journal. The Editorial makes a strong pitch for a systematic adoption of pro-poor strategies to bolster the adoption of UHC. In this commentary authored by the … Continue reading

Rate this:

EqualHealth Opens up Social Medicine Course
#MedEd / Medcetera / Public Health

EqualHealth Opens up Social Medicine Course

From the EqualHealth website: Beyond the Biological Basis of Disease: The Social and Economic Causation of Illness is offered by EqualHealth in collaboration with SocMed, an organization that advocates for and implements global health curricula founded on the study of social medicine. EqualHealth is excited to expand upon SocMed’s well-established curriculum to focus on the specific … Continue reading

Rate this: